Consult Your Provider: They may suggest staying at a lower dose for an extra month rather than moving up, which is often more effective than skipping weeks entirely
*Please note GLP-1 medication is billed separately and not covered in the program cost
Surface functionalization further enhances their properties
We recently introduced new options for patients to prepay and save when they sign up for 3, 6, or 12 month plans
Asia Pacific to Register Fastest Growth at 14.1% CAGR Through Forecast Period The Asia Pacific GLP-1 receptor agonist market is projected to witness the fastest growth rate of CAGR 14.1% during the forecast period, driven by a rapidly rising prevalence of diabetes and obesity across major economies such as China, India, and Japan
Retatrutide is primarily used as a research peptide for studying coordinated signaling between the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors